Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era
Open Access
- 1 April 2020
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 594 (24), 4233-4246
- https://doi.org/10.1002/1873-3468.13781
Abstract
One of the key challenges of cancer biology is to catalogue and understand the somatic genomic alterations leading to cancer. Although alternative definitions and search methods have been developed to identify cancer driver genes and mutations, analyses of thousands of cancer genomes return a remarkably similar catalogue of around 300 genes that are mutated in at least one cancer type. Yet, many features of these genes and their role in cancer remain unclear, first and foremost when a somatic mutation is truly oncogenic. In this review, we first summarize some of the recent efforts in completing the catalogue of cancer driver genes. Then, we give an overview of different aspects that influence the oncogenicity of somatic mutations in the core cancer driver genes, including their interactions with the germline genome, other cancer driver mutations, the immune system or their potential role in healthy tissues. In coming years, this research holds promise to illuminate how, when and why cancer driver genes and mutations are really drivers, and thereby move personalized cancer medicine and targeted therapies forward.Keywords
Funding Information
- National Institute of General Medical Sciences (GM118187)
This publication has 98 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Predicting the functional consequences of cancer-associated amino acid substitutionsBioinformatics, 2013
- Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α ( PIK3CA )Proceedings of the National Academy of Sciences, 2012
- CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancerBioinformatics, 2011
- dmGWAS: dense module searching for genome-wide association studies in protein–protein interaction networksBioinformatics, 2010
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- International network of cancer genome projectsNature, 2010
- Historical contingency and the evolution of a key innovation in an experimental population ofEscherichia coliProceedings of the National Academy of Sciences, 2008
- Walking the Interactome for Prioritization of Candidate Disease GenesAmerican Journal of Human Genetics, 2008
- A census of human cancer genesNature Reviews Cancer, 2004